APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Damage Response Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global DNA Damage Response Drugs Industry Growth and Trends Forecast to 2032

31 December 2025114 pages

Choose your research edition.

Industry ResearchDNA Damage Response Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Damage Response Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal DNA Damage Response Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Damage Response Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Damage Response Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global DNA Damage Response Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for DNA Damage Response Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for DNA Damage Response Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Damage Response Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the DNA Damage Response Drugs market include Merck, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Zentalis Pharmaceuticals, Sierra Oncology, Repare Therapeutics and Onxeo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global DNA Damage Response Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DNA Damage Response Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DNA Damage Response Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DNA Damage Response Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global DNA Damage Response Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DNA Damage Response Drugs Market by Company

Merck

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Zentalis Pharmaceuticals

Sierra Oncology

Repare Therapeutics

Onxeo

NMS Group SpA

Eli Lilly and Company

Debiopharm

Clovis Oncology

BeiGene

AbbVie Inc

DNA Damage Response Drugs Segment by Type

Lynparza

Rubraca

Talzenna

Zejula

DNA Damage Response Drugs Segment by Application

Pancreatic Cancer

Breast Cancer

Prostate Cancer

Ovarian Cancer

DNA Damage Response Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Damage Response Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Damage Response Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Damage Response Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of DNA Damage Response Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global DNA Damage Response Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global DNA Damage Response Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global DNA Damage Response Drugs Market Share by Region (2021-2026) Table 4. Global DNA Damage Response Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global DNA Damage Response Drugs Market Share by Region (2027-2032) Table 6. Global DNA Damage Response Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global DNA Damage Response Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global DNA Damage Response Drugs Market Size Share by Type (2021-2026) Table 9. Global DNA Damage Response Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global DNA Damage Response Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America DNA Damage Response Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe DNA Damage Response Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific DNA Damage Response Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America DNA Damage Response Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa DNA Damage Response Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global DNA Damage Response Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global DNA Damage Response Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global DNA Damage Response Drugs Market Size Share by Application (2021-2026) Table 24. Global DNA Damage Response Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global DNA Damage Response Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America DNA Damage Response Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe DNA Damage Response Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific DNA Damage Response Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America DNA Damage Response Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa DNA Damage Response Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. DNA Damage Response Drugs Industry Trends Table 37. DNA Damage Response Drugs Industry Drivers Table 38. DNA Damage Response Drugs Industry Opportunities and Challenges Table 39. DNA Damage Response Drugs Industry Restraints Table 40. Global DNA Damage Response Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global DNA Damage Response Drugs Revenue Market Share by Company (2021-2026) Table 42. Global DNA Damage Response Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global DNA Damage Response Drugs Key Company Headquarters & Area Served Table 44. Global DNA Damage Response Drugs Company, Product Type & Application Table 45. Global DNA Damage Response Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global DNA Damage Response Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck Company Information Table 49. Merck Business Overview Table 50. Merck DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck DNA Damage Response Drugs Product Portfolio Table 52. Merck Recent Development Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer DNA Damage Response Drugs Product Portfolio Table 57. Pfizer Recent Development Table 58. GlaxoSmithKline Company Information Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GlaxoSmithKline DNA Damage Response Drugs Product Portfolio Table 62. GlaxoSmithKline Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bayer DNA Damage Response Drugs Product Portfolio Table 67. Bayer Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca DNA Damage Response Drugs Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Zentalis Pharmaceuticals Company Information Table 74. Zentalis Pharmaceuticals Business Overview Table 75. Zentalis Pharmaceuticals DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Zentalis Pharmaceuticals DNA Damage Response Drugs Product Portfolio Table 77. Zentalis Pharmaceuticals Recent Development Table 78. Sierra Oncology Company Information Table 79. Sierra Oncology Business Overview Table 80. Sierra Oncology DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sierra Oncology DNA Damage Response Drugs Product Portfolio Table 82. Sierra Oncology Recent Development Table 83. Repare Therapeutics Company Information Table 84. Repare Therapeutics Business Overview Table 85. Repare Therapeutics DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Repare Therapeutics DNA Damage Response Drugs Product Portfolio Table 87. Repare Therapeutics Recent Development Table 88. Onxeo Company Information Table 89. Onxeo Business Overview Table 90. Onxeo DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Onxeo DNA Damage Response Drugs Product Portfolio Table 92. Onxeo Recent Development Table 93. NMS Group SpA Company Information Table 94. NMS Group SpA Business Overview Table 95. NMS Group SpA DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. NMS Group SpA DNA Damage Response Drugs Product Portfolio Table 97. NMS Group SpA Recent Development Table 98. Eli Lilly and Company Company Information Table 99. Eli Lilly and Company Business Overview Table 100. Eli Lilly and Company DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Eli Lilly and Company DNA Damage Response Drugs Product Portfolio Table 102. Eli Lilly and Company Recent Development Table 103. Debiopharm Company Information Table 104. Debiopharm Business Overview Table 105. Debiopharm DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Debiopharm DNA Damage Response Drugs Product Portfolio Table 107. Debiopharm Recent Development Table 108. Clovis Oncology Company Information Table 109. Clovis Oncology Business Overview Table 110. Clovis Oncology DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Clovis Oncology DNA Damage Response Drugs Product Portfolio Table 112. Clovis Oncology Recent Development Table 113. BeiGene Company Information Table 114. BeiGene Business Overview Table 115. BeiGene DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BeiGene DNA Damage Response Drugs Product Portfolio Table 117. BeiGene Recent Development Table 118. AbbVie Inc Company Information Table 119. AbbVie Inc Business Overview Table 120. AbbVie Inc DNA Damage Response Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AbbVie Inc DNA Damage Response Drugs Product Portfolio Table 122. AbbVie Inc Recent Development Table 123. North America DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America DNA Damage Response Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. North America DNA Damage Response Drugs Market Share by Country (2021-2026) Table 126. North America DNA Damage Response Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America DNA Damage Response Drugs Market Share Forecast by Country (2027-2032) Table 128. Europe DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe DNA Damage Response Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe DNA Damage Response Drugs Market Share by Country (2021-2026) Table 131. Europe DNA Damage Response Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe DNA Damage Response Drugs Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific DNA Damage Response Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific DNA Damage Response Drugs Market Share by Country (2021-2026) Table 136. Asia-Pacific DNA Damage Response Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific DNA Damage Response Drugs Market Share Forecast by Country (2027-2032) Table 138. Latin America DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America DNA Damage Response Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America DNA Damage Response Drugs Market Share by Country (2021-2026) Table 141. Latin America DNA Damage Response Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America DNA Damage Response Drugs Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa DNA Damage Response Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa DNA Damage Response Drugs Market Share by Country (2021-2026) Table 146. Middle East & Africa DNA Damage Response Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa DNA Damage Response Drugs Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. DNA Damage Response Drugs Product Image Figure 3. Global DNA Damage Response Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global DNA Damage Response Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global DNA Damage Response Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global DNA Damage Response Drugs Market Share by Region (2021-2032) Figure 7. North America DNA Damage Response Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe DNA Damage Response Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific DNA Damage Response Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America DNA Damage Response Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa DNA Damage Response Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Lynparza Image Figure 13. Global Lynparza Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Rubraca Image Figure 15. Global Rubraca Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Talzenna Image Figure 17. Global Talzenna Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Zejula Image Figure 19. Global Zejula Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global DNA Damage Response Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global DNA Damage Response Drugs Market Share by Type 2025 VS 2032 Figure 22. North America DNA Damage Response Drugs Market Size Share by Type (2021-2032) Figure 23. Europe DNA Damage Response Drugs Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific DNA Damage Response Drugs Market Size Share by Type (2021-2032) Figure 25. Latin America DNA Damage Response Drugs Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa DNA Damage Response Drugs Market Size Share by Type (2021-2032) Figure 27. Pancreatic Cancer Image Figure 28. Global Pancreatic Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Breast Cancer Image Figure 30. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Prostate Cancer Image Figure 32. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Ovarian Cancer Image Figure 34. Global Ovarian Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global DNA Damage Response Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global DNA Damage Response Drugs Market Share by Application 2025 VS 2032 Figure 37. North America DNA Damage Response Drugs Market Size Share by Application (2021-2032) Figure 38. Europe DNA Damage Response Drugs Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific DNA Damage Response Drugs Market Size Share by Application (2021-2032) Figure 40. Latin America DNA Damage Response Drugs Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa DNA Damage Response Drugs Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 DNA Damage Response Drugs Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America DNA Damage Response Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America DNA Damage Response Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America DNA Damage Response Drugs Market Share by Country (2021-2032) Figure 47. Europe DNA Damage Response Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe DNA Damage Response Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe DNA Damage Response Drugs Market Share by Country (2021-2032) Figure 50. Asia-Pacific DNA Damage Response Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific DNA Damage Response Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific DNA Damage Response Drugs Market Share by Country (2021-2032) Figure 53. Latin America DNA Damage Response Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America DNA Damage Response Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America DNA Damage Response Drugs Market Share by Country (2021-2032) Figure 56. Middle East & Africa DNA Damage Response Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa DNA Damage Response Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa DNA Damage Response Drugs Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Lynparza
  • Rubraca
  • Talzenna
  • Zejula
Applications
  • Pancreatic Cancer
  • Breast Cancer
  • Prostate Cancer
  • Ovarian Cancer
Companies covered
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Zentalis Pharmaceuticals
  • Sierra Oncology
  • Repare Therapeutics
  • Onxeo
  • NMS Group SpA
  • Eli Lilly and Company
  • Debiopharm
  • Clovis Oncology
  • BeiGene
  • AbbVie Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global DNA Damage Response Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global DNA Damage Response Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global DNA Damage Response Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global DNA Damage Response Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions DNA Damage Response Drugs Market Size (2021-2032)
  8. 1.5.1 North America DNA Damage Response Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe DNA Damage Response Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific DNA Damage Response Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America DNA Damage Response Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa DNA Damage Response Drugs Market Size Growth Rate (2021-2032)
2 DNA Damage Response Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Lynparza
  3. 2.1.2 Rubraca
  4. 2.1.3 Talzenna
  5. 2.1.4 Zejula
  6. 2.2 Global DNA Damage Response Drugs Market Size by Type
  7. 2.2.1 Global DNA Damage Response Drugs Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global DNA Damage Response Drugs Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global DNA Damage Response Drugs Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global DNA Damage Response Drugs Market Size by Regions
  11. 2.3.1 North America DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa DNA Damage Response Drugs Market Size Breakdown by Type (2021-2026)
3 DNA Damage Response Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pancreatic Cancer
  3. 3.1.2 Breast Cancer
  4. 3.1.3 Prostate Cancer
  5. 3.1.4 Ovarian Cancer
  6. 3.2 Global DNA Damage Response Drugs Market Size by Application
  7. 3.2.1 Global DNA Damage Response Drugs Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global DNA Damage Response Drugs Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global DNA Damage Response Drugs Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global DNA Damage Response Drugs Market Size by Regions
  11. 3.3.1 North America DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa DNA Damage Response Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 DNA Damage Response Drugs Industry Trends
  2. 4.2 DNA Damage Response Drugs Industry Drivers
  3. 4.3 DNA Damage Response Drugs Industry Opportunities and Challenges
  4. 4.4 DNA Damage Response Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by DNA Damage Response Drugs Revenue (2021-2026)
  2. 5.2 Global DNA Damage Response Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global DNA Damage Response Drugs Key Company Headquarters & Area Served
  4. 5.4 Global DNA Damage Response Drugs Company, Product Type & Application
  5. 5.5 Global DNA Damage Response Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global DNA Damage Response Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 DNA Damage Response Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 DNA Damage Response Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck DNA Damage Response Drugs Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer DNA Damage Response Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline DNA Damage Response Drugs Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bayer DNA Damage Response Drugs Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca DNA Damage Response Drugs Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Zentalis Pharmaceuticals
  32. 6.6.1 Zentalis Pharmaceuticals Company Information
  33. 6.6.2 Zentalis Pharmaceuticals Business Overview
  34. 6.6.3 Zentalis Pharmaceuticals DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Zentalis Pharmaceuticals DNA Damage Response Drugs Product Portfolio
  36. 6.6.5 Zentalis Pharmaceuticals Recent Developments
  37. 6.7 Sierra Oncology
  38. 6.7.1 Sierra Oncology Company Information
  39. 6.7.2 Sierra Oncology Business Overview
  40. 6.7.3 Sierra Oncology DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sierra Oncology DNA Damage Response Drugs Product Portfolio
  42. 6.7.5 Sierra Oncology Recent Developments
  43. 6.8 Repare Therapeutics
  44. 6.8.1 Repare Therapeutics Company Information
  45. 6.8.2 Repare Therapeutics Business Overview
  46. 6.8.3 Repare Therapeutics DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Repare Therapeutics DNA Damage Response Drugs Product Portfolio
  48. 6.8.5 Repare Therapeutics Recent Developments
  49. 6.9 Onxeo
  50. 6.9.1 Onxeo Company Information
  51. 6.9.2 Onxeo Business Overview
  52. 6.9.3 Onxeo DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Onxeo DNA Damage Response Drugs Product Portfolio
  54. 6.9.5 Onxeo Recent Developments
  55. 6.10 NMS Group SpA
  56. 6.10.1 NMS Group SpA Company Information
  57. 6.10.2 NMS Group SpA Business Overview
  58. 6.10.3 NMS Group SpA DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 NMS Group SpA DNA Damage Response Drugs Product Portfolio
  60. 6.10.5 NMS Group SpA Recent Developments
  61. 6.11 Eli Lilly and Company
  62. 6.11.1 Eli Lilly and Company Company Information
  63. 6.11.2 Eli Lilly and Company Business Overview
  64. 6.11.3 Eli Lilly and Company DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Eli Lilly and Company DNA Damage Response Drugs Product Portfolio
  66. 6.11.5 Eli Lilly and Company Recent Developments
  67. 6.12 Debiopharm
  68. 6.12.1 Debiopharm Company Information
  69. 6.12.2 Debiopharm Business Overview
  70. 6.12.3 Debiopharm DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Debiopharm DNA Damage Response Drugs Product Portfolio
  72. 6.12.5 Debiopharm Recent Developments
  73. 6.13 Clovis Oncology
  74. 6.13.1 Clovis Oncology Company Information
  75. 6.13.2 Clovis Oncology Business Overview
  76. 6.13.3 Clovis Oncology DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Clovis Oncology DNA Damage Response Drugs Product Portfolio
  78. 6.13.5 Clovis Oncology Recent Developments
  79. 6.14 BeiGene
  80. 6.14.1 BeiGene Company Information
  81. 6.14.2 BeiGene Business Overview
  82. 6.14.3 BeiGene DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BeiGene DNA Damage Response Drugs Product Portfolio
  84. 6.14.5 BeiGene Recent Developments
  85. 6.15 AbbVie Inc
  86. 6.15.1 AbbVie Inc Company Information
  87. 6.15.2 AbbVie Inc Business Overview
  88. 6.15.3 AbbVie Inc DNA Damage Response Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AbbVie Inc DNA Damage Response Drugs Product Portfolio
  90. 6.15.5 AbbVie Inc Recent Developments
7 North America
  1. 7.1 North America DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America DNA Damage Response Drugs Market Size by Country (2021-2026)
  3. 7.3 North America DNA Damage Response Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe DNA Damage Response Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe DNA Damage Response Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific DNA Damage Response Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific DNA Damage Response Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America DNA Damage Response Drugs Market Size by Country (2021-2026)
  3. 10.3 South America DNA Damage Response Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa DNA Damage Response Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa DNA Damage Response Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa DNA Damage Response Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst